Safe Treatment for Emergency Presentation for Suicidal Ideation and Behavior in Youth
SAFE STEPS
Youth Partners in Care for Suicide Prevention
1 other identifier
interventional
1,600
1 country
5
Brief Summary
This randomized comparative effectiveness trial will compare two evidence-based approaches to emergency care for youth ages 13-24 who present to the Emergency Department (ED) with suicidal ideation or behavior. Outcomes will be monitored at baseline and at 3, 6 \& 12 month follow-up assessments.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started Oct 2022
Typical duration for phase_2
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 11, 2022
CompletedFirst Posted
Study publicly available on registry
March 31, 2022
CompletedStudy Start
First participant enrolled
October 17, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
December 31, 2025
December 1, 2025
4.2 years
March 11, 2022
December 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Suicide Attempts: Primary Clinical Outcome
suicide attempts fatal, nonfatal, and interrupted
Through 12 months of follow-up
Mental Health Treatment Initiation: Primary Service Use Outcome
initiation of mental health treatment after discharge from ED/hospital
Observed through 12 months of follow-up, primary end point 6-month follow-up
Secondary Outcomes (2)
Self-Harm: Secondary Clinical Outcome
Through 12 months of follow-up
Treatment engagement: Secondary Service Use Outcome
Through 12 months of follow-up
Other Outcomes (2)
Ordinal suicidality scale: Clinical
Through 12 months of follow-up
Quality of life and functioning: Clinical
Change from baseline through 12 months of follow-up
Study Arms (2)
SAFETY-Acute within Usual ED Care
ACTIVE COMPARATORThe SAFETY-Acute (A) approach to safety planning and stabilization will be integrated within usual ED Care. SAFETY-A was formerly called the Family Intervention for Suicide Prevention, FISP.
Combined
ACTIVE COMPARATORThe combined treatment arm includes both 1) SAFETY-A integrated within usual ED Care, and 2) therapeutic follow-up contacts using the Coping Long Term with Active Suicidality Program (CLASP) model.
Interventions
SAFETY-A is a single session collaborative, strengths-based, developmentally nuanced, cognitive-behavioral intervention (CBT) to increase safety and mental health treatment initiation. The therapist works with the youth and family (or significant other, SO) separately and together to build hope and reasons for living, develop a personal safety plan, increase protective supports; and increase motivation for and linkage to treatment.
COMB, includes SAFETY-A within usual ED care plus CLASP therapeutic and caring follow-up contacts designed to strengthen safety and treatment initiation and engagement. Core functions of CLASP include: building hope/reducing hopelessness; enhancing social/family support; strengthening problem-solving; and increasing treatment initiation and engagement.
Eligibility Criteria
You may qualify if:
- age 13-24;
- past-week suicidal behavior or ideation with plan or intent
You may not qualify if:
- symptoms or illness that precludes informed consent or engagement in study procedures (e.g., active psychosis; drug dependence, no locator information);
- youth not fluent in English
- parent not fluent in English or Spanish.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Brown Universitycollaborator
- University of Utahcollaborator
- Olive View-UCLA Education & Research Institutecollaborator
- RANDcollaborator
- Patient-Centered Outcomes Research Institutecollaborator
- University of California, Los Angeleslead
- Duke Universitycollaborator
Study Sites (5)
Ronald Reagan Medical Center
Los Angeles, California, 90095-6968, United States
Olive View UCLA Education and Research Center
Sylmar, California, 91342, United States
Duke University
Durham, North Carolina, 27708, United States
Brown University
Providence, Rhode Island, 02912, United States
University of Utah
Salt Lake City, Utah, 84112, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joan R Asarnow, PhD
University of California, Los Angeles
- PRINCIPAL INVESTIGATOR
David Goldston, PhD
Duke University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Masking Details
- It is not possible to mask intervention condition from participants. Care providers in the ED will be masked to randomized condition. Outcomes assessors will be masked to randomized condition.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Psychiatry & Biboehavioral Sciences
Study Record Dates
First Submitted
March 11, 2022
First Posted
March 31, 2022
Study Start
October 17, 2022
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
December 31, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- A limited data set may be available after all data are complete, analyzed, and published. Time frame and plan will be developed by investigators in collaboration with stakeholders and funding agency (PCORI).
- Access Criteria
- Decision will be made with PCORI, project investigators, and stakeholders regarding any data access. Given rarity of suicide attempts it is critical that participant confidentiality be maintained and steps be taken to protect against the possibility of unintended loss of anonymity due to focus on rare outcomes.
Decision will be made with PCORI, project investigators, and stakeholders regarding any data sharing. Given relative rarity of suicide attempts it is critical that participant confidentiality be maintained and steps be taken to protect against the possible of unintended loss of anonymity due to focus on rare outcome.